Remote National Accounts Director, Managed Markets

Hikma Pharmaceuticals; Berkeley Heights (NJ); On-site; USD 121,000 - 185,000; Full time

Benefits offered by this job

Annual performance bonus

401(k) with company match

PTO and parental leave

Job summary

Hikma Pharmaceuticals USA Inc. seeks an Associate Director, National Accounts, Managed Markets, for a remote role. You will build and manage national payer relationships, negotiate coverage and reimbursement strategies, and drive formulary access across large payers.

Strong collaboration with marketing, sales, and legal is required. Ideal candidates have 5+ years in Market Access with national payers, robust negotiation skills, and a track record of securing formulary status for brand,

Qualifications

• BA/BS degree required; MBA or advanced degree preferred.
• 5+ years of pharmaceutical/biotech Market Access experience with national payers/PBMs.
• Strong negotiation and launch experience with pre- and post-PDUFA market prep.
• Proven ability to win preferred formulary status for brand products.

Responsibilities

• Negotiate and develop national payer strategies for formulary placement and access.
• Lead relationships with national payers and PBMs; drive reimbursement and coverage.
• Coordinate with marketing, field sales, and legal to align market access activities.
• Develop account-specific business plans and lead contract negotiations.

Skills

Negotiation

Strategic marketing

Collaboration

Presentation

Integrity

Commercial acumen

Education

BA/BS degree

MBA or advanced degree

Tools

Excel

PowerPoint

Word

Job description

Hikma Pharmaceuticals USA Inc. seeks an Associate Director, National Accounts, Managed Markets, for a remote role. You will build and manage national payer relationships, negotiate coverage and reimbursement strategies, and drive formulary access across large payers.

Strong collaboration with marketing, sales, and legal is required. Ideal candidates have 5+ years in Market Access with national payers, robust negotiation skills, and a track record of securing formulary status for brand,